רגולציה ולגלזציה

Rescheduling could ease marijuana advertising ban; Anti-cannabis group’s plans; MA possession limit increase; NY market report Subscribe to receive Marijuana Moment’s newsletter in your inbox every weekday morning. It’s the best way to make sure you know which cannabis stories are shaping the day. Your support makes Marijuana Moment possible… Your good deed for the day:…

A political committee funded by major marijuana businesses has contributed an additional $1.05 million to President Donald Trump’s MAGA Inc. super PAC in the months leading up to his rescheduling order, FEC filings show. The American Rights and Reform PAC—which initially launched in 2023 under a different name, Legalize America, and lists an executive at…

The Drug Enforcement Administration (DEA) has finalized quotas for legal production of controlled substances in 2026—further raising the amount of certain psychedelics that can be made for research purposes in the new year. In a notice published in the Federal Register on Monday, DEA increased its quotas for psilocybin, psilocyn and DMT compared to what…

A GOP senator says his opposition to marijuana reform—and his conviction that cannabis is a “gateway drug”—hasn’t changed even after President Donald Trump signed a rescheduling order. Asked about the president’s directive to move marijuana from Schedule I to Schedule III of the Controlled Substances Act (CSA), Sen. Rick Scott (R-FL) told Marijuana Moment that…

The Drug Enforcement Administration (DEA) says the marijuana rescheduling appeal process “remains pending” despite President Donald Trump’s recent executive order directing the attorney general to finish the job “in the most expeditious manner.” DEA and reform proponents on Monday submitted a joint status report on an interlocutory appeal that concerns allegations of agency bias and…